Efficacy and Safety of Diode Laser Transscleral Cyclophotocoagulation in Patients with Glaucoma
Clinical Ophthalmology · 2024-08 · Volume 18 · 2271-2279
DOI: 10.2147/opth.s473788 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ophthalmology, 2024-08. Verfasst von Margarida Ribeiro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Unidade Local de Saúde de São João, Porto, Portugal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
To evaluate the efficacy and safety of transscleral diode cyclophotocoagulation (TSCPC) at 2 years of follow up.
Methods
This is a retrospective review of the records of all adult patients who underwent their first TSCPC treatment between 2014 and 2019 at Unidade Local de Saúde de São João, Porto, Portugal. Data regarding intraocular pressure (IOP), best corrected visual acuity, number of IOP-lowering medications, use of oral acetazolamide, retreatments and complications during a 2-year period following TSCPC were registered. The primary outcome was overall success at 2 years, defined as IOP≥ 6 and ≤21 mmHg, with at least 20% IOP reduction from baseline, with or without IOP-lowering medications (qualified and complete success, respectively), without the development of phthisis bulbi or loss of light perception due to glaucoma and no further glaucoma procedures except TSCPC retreatment.
Results
Ninety-six eyes from 96 patients were included, mean age was 63 (±14) years. Mean IOP at baseline was 39.1 (±13.3) mmHg. Mean IOP reduction at 2 years was 18.5 (42.9%) mmHg (±16.0, min -16.0, max 56.0) (p < 0.001) and a significant reduction in the number of IOP-lowering medications and use of oral acetazolamide was observed. IOP reduction at 2 years was positively correlated with baseline IOP (r=0.682; p < 0.001). Overall success (including complete and qualified) was achieved in 42 patients (43.8%), with 34 (35.4%) presenting qualified success. Neovascular glaucoma (NVG) was the predominant diagnosis (n = 30, 31.3%), with a higher mean baseline IOP of 46.3 mmHg (±11.8, min 21.0, max 70.0) and a larger mean IOP reduction at 2 years of 24.7 (51.0%) mmHg (±16.4, min -2.0, max 55.0). Thirteen patients (13.5%) developed persistent hypotony, eight of which converted to phthisis bulbi, of which half had NVG.
Conclusion
TSCPC can be an effective IOP-lowering procedure, demonstrating a stronger effect when the preoperative IOP is highest. However, there is a wide variability in the effect (specially in eyes with NVG) and some relevant complications, including 8.3% of patients developing phthisis bulbi after 2 years of follow up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Unidade Local de Saúde de São João, Porto, Portugal.
- Department of Biomedicine - Unit of Pharmacology and Therapeutics, Faculty of Medicine of the University of Porto, Porto, Portugal.
- Faculty of Medicine of the University of Porto, Porto, Portugal.
- Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal.
- UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal.
- KULeuven, Research Group Ophthalmology, Department of Neurosciences, Leuven, Belgium.
ORCID-Profile: Margarida Ribeiro, Mário Lima-Fontes, Sérgio Estrela-Silva, António Benevides Melo, João Tavares-Ferreira, João Barbosa-Breda
Zitieren
APA
Ribeiro, M., Freitas, J. N., Lima-Fontes, M., Leuzinger-Dias, M., Silva, M. I., Araújo, J., Estrela-Silva, S., Melo, A. B., Tavares-Ferreira, J., Alves, F., & Barbosa-Breda, J. (2024). Efficacy and Safety of Diode Laser Transscleral Cyclophotocoagulation in Patients with Glaucoma. Clinical Ophthalmology, Volume 18, 2271-2279. https://doi.org/10.2147/opth.s473788
Vancouver
Ribeiro M, Freitas JN, Lima-Fontes M, Leuzinger-Dias M, Silva MI, Araújo J, et al. Efficacy and Safety of Diode Laser Transscleral Cyclophotocoagulation in Patients with Glaucoma. Clinical Ophthalmology. 2024;Volume 18:2271-2279. doi:10.2147/opth.s473788
BibTeX
@article{Ribeiro2024,
author = {Ribeiro, Margarida and Freitas, João Nogueira and Lima-Fontes, Mário and Leuzinger-Dias, Mariana and Silva, Marta Inês and Araújo, Joana and Estrela-Silva, Sérgio and Melo, António Benevides and Tavares-Ferreira, João and Alves, Flávio and Barbosa-Breda, João},
title = {Efficacy and Safety of Diode Laser Transscleral Cyclophotocoagulation in Patients with Glaucoma},
journal = {Clinical Ophthalmology},
year = {2024},
volume = {Volume 18},
pages = {2271--2279},
doi = {10.2147/opth.s473788}
}
EUVIMED